Details
Stereochemistry | RACEMIC |
Molecular Formula | C19H22N2 |
Molecular Weight | 278.3914 |
Optical Activity | ( + / - ) |
Defined Stereocenters | 0 / 1 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
CC(CC(C#N)(C1=CC=CC=C1)C2=CC=CC=C2)N(C)C
InChI
InChIKey=GJJQIGFCGLPOQK-UHFFFAOYSA-N
InChI=1S/C19H22N2/c1-16(21(2)3)14-19(15-20,17-10-6-4-7-11-17)18-12-8-5-9-13-18/h4-13,16H,14H2,1-3H3
CNS Activity
Sources: https://www.ncbi.nlm.nih.gov/pubmed/20239733
Curator's Comment: CNS active in rats
Originator
Approval Year
Conditions
Condition | Modality | Targets | Highest Phase | Product |
---|---|---|---|---|
Sources: https://www.ncbi.nlm.nih.gov/pubmed/20239733 |
Primary | Unknown Approved UseUnknown |
Sample Use Guides
In Vivo Use Guide
Sources: https://www.ncbi.nlm.nih.gov/pubmed/20239733
To study the analgetic effect of didiavalo the drug was administered to rats intravenously. Didiavalo was 30 times less potent than morphine, with effects of dose 60 mg/kg similar to the effect of 2.0 mg/kg morphine.
Route of Administration:
Intravenous
Name | Type | Language | ||
---|---|---|---|---|
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Code | English | ||
|
Code | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English |
Classification Tree | Code System | Code | ||
---|---|---|---|---|
|
DEA NO. |
9254
Created by
admin on Fri Dec 15 15:14:49 GMT 2023 , Edited by admin on Fri Dec 15 15:14:49 GMT 2023
|
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
50382
Created by
admin on Fri Dec 15 15:14:49 GMT 2023 , Edited by admin on Fri Dec 15 15:14:49 GMT 2023
|
PRIMARY | |||
|
204-755-9
Created by
admin on Fri Dec 15 15:14:49 GMT 2023 , Edited by admin on Fri Dec 15 15:14:49 GMT 2023
|
PRIMARY | |||
|
0GYB2HJA89
Created by
admin on Fri Dec 15 15:14:49 GMT 2023 , Edited by admin on Fri Dec 15 15:14:49 GMT 2023
|
PRIMARY | |||
|
DTXSID1048912
Created by
admin on Fri Dec 15 15:14:49 GMT 2023 , Edited by admin on Fri Dec 15 15:14:49 GMT 2023
|
PRIMARY | |||
|
1398020
Created by
admin on Fri Dec 15 15:14:49 GMT 2023 , Edited by admin on Fri Dec 15 15:14:49 GMT 2023
|
PRIMARY | |||
|
31331
Created by
admin on Fri Dec 15 15:14:49 GMT 2023 , Edited by admin on Fri Dec 15 15:14:49 GMT 2023
|
PRIMARY | |||
|
125-79-1
Created by
admin on Fri Dec 15 15:14:49 GMT 2023 , Edited by admin on Fri Dec 15 15:14:49 GMT 2023
|
PRIMARY | |||
|
Methadone intermediate
Created by
admin on Fri Dec 15 15:14:49 GMT 2023 , Edited by admin on Fri Dec 15 15:14:49 GMT 2023
|
PRIMARY | |||
|
2089
Created by
admin on Fri Dec 15 15:14:49 GMT 2023 , Edited by admin on Fri Dec 15 15:14:49 GMT 2023
|
PRIMARY |
SUBSTANCE RECORD